regeneus logo.png
Regeneus
(ASX:RGS)

Overview

Regeneus Ltd (ASX: RGS) is an Australian clinical-stage regenerative medicine company developing a portfolio of innovative cellular therapies targeting significant unmet medical needs with a licence driven strategy.

Our Latest Articles on Regeneus


Type Date Title
Article 02-Mar-2020 Can This ASX Junior Surge Through the Pain Barrier?

Market Data


Latest Article

Can This ASX Junior Surge Through the Pain Barrier?

Can This ASX Junior Surge Through the Pain Barrier?

Biotech company Regeneus (ASX:RGS) is a regenerative medicine company, and the therapy is a novel stem cell therapy.

Thanks for subscribing!

X